Zobrazeno 1 - 10
of 559
pro vyhledávání: '"Vaena D"'
Autor:
Agarwal, N. 1, ∗, Brugarolas, J. 2, 3, Ghatalia, P. 4, George, S. 5, Haanen, J.B. 6, Gurney, H. 7, Ravilla, R. 8, Van der Veldt, A. 9, Beuselinck, B. 10, Pokataev, I. 11, Suelmann, B.B.M. 12, Tuthill, M.H. 13, Vaena, D. 14, Zagouri, F. 15, Wu, J. 16, Perini, R.F. 16, Liu, Y. 16, Merchan, J. 17, Atkins, M.B. 18
Publikováno v:
In Annals of Oncology December 2024 35(12):1148-1156
Autor:
Stricker T; Tennessee Oncology, Nashville, TN, USA.; OneOncology LLC, Nashville, TN, USA., Jain N; OneOncology LLC, Nashville, TN, USA., Ma E; Genentech, Inc., South San Francisco, CA, USA., Yu E; Genentech, Inc., South San Francisco, CA, USA., Wang R; Genentech, Inc., South San Francisco, CA, USA., Schuldt R; Genentech, Inc., South San Francisco, CA, USA., Price R; Genentech, Inc., South San Francisco, CA, USA., Szado T; Genentech, Inc., South San Francisco, CA, USA., Sussell J; Genentech, Inc., South San Francisco, CA, USA., Ogale S; Genentech, Inc., South San Francisco, CA, USA., Lin V; OneOncology LLC, Nashville, TN, USA.; Mary Bird Perkins Cancer Center, Baton Rouge, LA, USA., Arrowsmith E; Tennessee Oncology, Nashville, TN, USA.; OneOncology LLC, Nashville, TN, USA., Slater D; OneOncology LLC, Nashville, TN, USA.; Eastern Connecticut Hematology and Oncology, Norwich, CT, USA., Vaena D; OneOncology LLC, Nashville, TN, USA.; West Cancer Center & Research Institute, Germantown, TN, USA., Staszewski H; OneOncology LLC, Nashville, TN, USA.; New York Cancer & Blood Specialists, Port Jefferson Station, NY, USA., Fang B; OneOncology LLC, Nashville, TN, USA.; Astera Cancer Care, East Brunswick, NJ, USA., Seneviratne L; OneOncology LLC, Nashville, TN, USA.; Los Angeles Cancer Network, Los Angeles, CA, USA., Daniel D; Tennessee Oncology, Nashville, TN, USA.; OneOncology LLC, Nashville, TN, USA.
Publikováno v:
The oncologist [Oncologist] 2024 Jun 03; Vol. 29 (6), pp. 534-542.
Autor:
Moroney, J., Yeku, O., Fleming, G., Emens, L.A., Vaena, D., Dumbrava, E.E., Rasco, D., Sharma, M.R., Papadopoulos, K., Patnaik, A., Sullivan, R.J., Adewoye, H.H., Ophir, E., Cojocaru, G., Ferre, P.J., Izar, B., Gaillard, S.
Publikováno v:
In Immuno-Oncology and Technology December 2022 16 Supplement 1
Autor:
Yeku, O., D. Shepard, Patel, M., Fleming, G., Vaena, D., Rasco, D., Chmielowski, B., Sharma, M.R., Hamilton, E., Sullivan, R.J., Papadopoulos, K., Izar, B., Cojocaru, G., Ophir, E., Ferre, P.J., Dumbrava, E.E.
Publikováno v:
In Immuno-Oncology and Technology December 2022 16 Supplement 1
Autor:
Sullivan, R.J., Sharma, M.R., Vaena, D., Hamilton, E., Izar, B., Rasco, D., Gainor, J., D. Shepard, Papadopoulos, K., Dumbrava, E.E., Adewoye, H.H., Ferre, P.J., Ophir, E., Patel, M., Patnaik, A., Chmielowski, B.
Publikováno v:
In Immuno-Oncology and Technology December 2022 16 Supplement 1
Autor:
Valenzuela, Luis Fernández de Córdoba y Ayala,marqués de, Sesa y y Baena, Antonio Fernández de Córdoba y Rojas, Cardona y Aragón, duque de, Herrera Pareja, Juan de
Publikováno v:
idUS: Depósito de Investigación de la Universidad de Sevilla
Universidad de Sevilla (US)
idUS. Depósito de Investigación de la Universidad de Sevilla
instname
Universidad de Sevilla (US)
idUS. Depósito de Investigación de la Universidad de Sevilla
instname
A FD/0105(23)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c7c2fd5285a32133fdcf162db1865c73
Autor:
Schwartzberg L; Renown Health Institute for Cancer, Reno, NV 89502, USA.; OneOncology, Inc., Nashville, TN 37219, USA., Daniel D; OneOncology, Inc., Nashville, TN 37219, USA.; Tennessee Oncology, Nashville, TN 37203, USA., Vaena D; OneOncology, Inc., Nashville, TN 37219, USA.; West Cancer Center & Research Institute, Germantown, TN 38138, USA., Slater D; OneOncology, Inc., Nashville, TN 37219, USA.; Eastern Connecticut Hematology & Oncology, Norwich, CT 06360, USA., Staszewski H; OneOncology, Inc., Nashville, TN 37219, USA.; New York Cancer & Blood Specialists, Port Jefferson Station, NY 11776, USA., Fang B; OneOncology, Inc., Nashville, TN 37219, USA.; Astera Cancer Care, East Brunswick, NJ 08816, USA., Seneviratne L; OneOncology, Inc., Nashville, TN 37219, USA.; Los Angeles Cancer Network, Los Angeles, CA 90017, USA., Yu E; Genentech, Inc., South San Francisco, CA 94080, USA., Price R; Genentech, Inc., South San Francisco, CA 94080, USA., Szado T; Genentech, Inc., South San Francisco, CA 94080, USA., Meyer CS; Janssen Pharmaceuticals of Johnson & Johnson, South San Francisco, CA 94080, USA., Shah A; Gilead Sciences, Inc., Foster City, CA 94404, USA., Ma E; Genentech, Inc., South San Francisco, CA 94080, USA.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2023 Jun; Vol. 19 (20), pp. 1397-1414. Date of Electronic Publication: 2023 Jun 15.
Autor:
Agarwal, N., Brugarolas, J., Ghatalia, P., George, S., Haanen, J.B.A.G., Gurney, H.P., Ravilla, R., Van der Veldt, A.A.M., Beuselinck, B., Pokataev, I., Suelmann, B.B., Tuthill, M., Vaena, D., Zagouri, F., Wu, J., Liu, Y., Perini, R., Merchan, J.R., Atkins, M.B.
Publikováno v:
In Annals of Oncology October 2023 34 Supplement 2:S1011-S1011
Autor:
ElNaggar A; Division of Gynecologic Oncology, West Cancer Center and Research Institute, Memphis, TN, USA., Zhang N; Department of Obstetrics and Gynecology, University of Tennessee Health Science Center, Memphis, TN, USA., Scalise CB; Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., Sirard C; Leap Therapeutics, Inc., Cambridge, MA, USA., Kagey MH; Leap Therapeutics, Inc., Cambridge, MA, USA., Vaena D; Division of Medical Oncology, West Cancer Center and Research Institute, Memphis, TN, USA., Arend R; Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.
Publikováno v:
Gynecologic oncology reports [Gynecol Oncol Rep] 2021 Dec 09; Vol. 39, pp. 100904. Date of Electronic Publication: 2021 Dec 09 (Print Publication: 2022).
Autor:
Elliott A; Department of Clinical and Translational Research, Caris Life Sciences, Inc., Phoenix, Arizona. Electronic address: aelliott@carisls.com., Zhang J; Department of Bioinformatics, Caris Life Sciences, Inc., Phoenix, Arizona., Zhang Q; Department of Bioinformatics, Caris Life Sciences, Inc., Phoenix, Arizona., Swensen J; Department of Genetics, Caris Life Sciences, Inc., Phoenix, Arizona., Martin D; Department of Bioinformatics, Caris Life Sciences, Inc., Phoenix, Arizona., Xiu J; Department of Clinical and Translational Research, Caris Life Sciences, Inc., Phoenix, Arizona., Geynisman DM; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Vaena D; Department of Medical Oncology, West Cancer Center, Germantown, Tennessee., Herzog TJ; Department of Obstetrics and Gynecology, University of Cincinnati, Cincinnati, Ohio., Holloway RW; Department of Gynecologic Oncology, Gynecologic Oncology Program, AdventHealth Cancer Institute, Orlando, Florida., El-Deiry WS; Department of Pathology and Laboratory Medicine, Warren Alpert Medical School, Brown University, Providence, Rhode Island., Spetzler D; Department of Research and Development, Caris Life Sciences, Inc., Phoenix, Arizona., Heath E; Department of Oncology, Wayne State University/Karmanos Cancer Institute, Detroit, Michigan., Stafford P; Department of Bioinformatics, Caris Life Sciences, Inc., Phoenix, Arizona., Korn WM; Department of Medical Affairs, Caris Life Sciences, Inc., Phoenix, Arizona; Division of Gastroenterology and Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
Publikováno v:
The Journal of molecular diagnostics : JMD [J Mol Diagn] 2021 Dec; Vol. 23 (12), pp. 1761-1773. Date of Electronic Publication: 2021 Sep 22.